Recent

% | $
Quotes you view appear here for quick access.

Ecotality, AŞ Message Board

me2yousee 134 posts  |  Last Activity: Apr 27, 2016 4:22 PM Member since: Feb 25, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Silence = Partnership In the Works

    by lrbecke2 Apr 27, 2016 3:42 PM
    me2yousee me2yousee Apr 27, 2016 4:22 PM Flag

    Nope, the winner will be GILD. This could be a MAJOR profit mover for them and they have major cash on hand for the acquisition. And they have nothing in this area to ruin their research since they don't do anything in this area.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 27, 2016 9:32 AM Flag

    Uncle Sam gives discounts for mistakes. All ya gotta do is sell.

    Sentiment: Strong Buy

  • Reply to

    Motley Fool Article

    by wicked_690hp_hellcat Apr 27, 2016 6:22 AM
    me2yousee me2yousee Apr 27, 2016 7:37 AM Flag

    It's the FDA that will say what is needed to be done. And since the FDA has been speaking very often to AVXL, my guess, is the conversation has come up long before this article.

    Even if the FDA were to be unfriendly, there are other strategies to execute. Take existing data to another agency to get approved first that is more .... open and objective, like Japan. They have old people. Quite a bit actually, as a percentage of the population. Launch it there and in other countries that accept the Japanese approval process to produce revenue and gather more data. Then work your way back to the more difficult / complicated agencies. By then, public opinion will be on their side for people desperate to get this. Just think how many congressman want to be able to stay in office longer.

    These "EXPERT" opinions just show how limited the authors are and what agendas they have.

    Sentiment: Strong Buy

  • I can't understand the mentality of retail shorts going after that last dime of an MACD cycle. Especially, with something with THIS potential. Oink, oink. Wake up, can't find news as to why, but they have to start scrambling for shares simply because somebody else is.

    A very high percentage of pre and after market trading, is short related. So one retail short panic buys to another retail short that takes a "better" position. While they laugh and comment against stupid longs, it is the shorts that fuel virtually ALL rocket launches. They simply cannibalize each other for that "magic" position.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 22, 2016 9:38 AM Flag

    Another possibility. There was a new type of analysis being applied to the data. Now ask yourself .... why? Why would AVXL pay more for data processing that isn't necessary under current FDA standards? Or is it because current FDA procedure hasn't developed squat for AD and the FDA wants to try something new?

    Could be at the request of the FDA for a myriad of reasons. All that seem good to me. Look this is ground breaking stuff on a product that really seems to work for patients. The FDA is excited and this may NOT go like any normal FDA approval process. And they could have a gag in place until a determination is made.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 19, 2016 7:11 AM Flag

    They all work at the same place and are cubicle buddies. Each month, one buys a copy of Motor Trend and they pass it around at work. At the end of the day, they take public transportation back to their parents place.

    Sentiment: Strong Buy

  • I expect new ETFs to be created that will be geared to "the head" this fall. The last big Bio theme was Immunotherapy for Cancer. Before that , it was gene therapy. Any bio that had anything to do in that area caught fire in the fall of 2014 and ZOOMMED up. IPO's came public. CALA tripled in a week. ADXS that had been out for awhile, went from low digits to $30. When the novelty of that sector dies, (using an already weakened body to fight it's own battle with cancer) so did the individual company stocks.

    Guess what, head diseases have numbers of patients that dwarf everything else. And now we are learning that many may be related. Head disease companies have lower burn rates for cash. Results can be measured / tracked inexpensively over reasonably short periods of time compared to other disease. And the FDA is receptive in this area for something that works. And the Government may start dolling out cash in this area too.

    The Heptares example is going to bring IPO's out by this fall. And that will get the ETF ball rolling. So while we have AVXL as an individual company, we may just get some extra market assistance in the months ahead. Don't forget the unpredictable events that might hit the stock outside of AVXL's control too. The Michael J. Fox tests come to mind as an example. Third party news like that, the FDA, and others will raise AVXL's credibility and price eventually.

    Sentiment: Strong Buy

  • We always get that noon time siesta till about 2:30. If they buy through it, could be a LOT more. That'll tell ya if this is a new ballgame (revaluation) or the same ol, same ol.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 8, 2016 9:04 AM Flag

    Yep, feed the gap. Rocket fuel is always appreciated.

    Sentiment: Strong Buy

  • Gaps are OK if they are of the break away variety.

    Now that we have a pipeline, AVXL should merit a higher market cap. At least 500 million for 2 multi billion dollar drugs.

    Sentiment: Strong Buy

  • Reply to

    FDA - Orphan Drug Act

    by red.birdfriend Apr 8, 2016 7:34 AM
    me2yousee me2yousee Apr 8, 2016 7:53 AM Flag

    Dumb FDA. Granted AVXL this for a sugar pill? :)

    Sentiment: Strong Buy

  • The shorts goin up in smoke.

    Now we gots us a pipeline for our 200 million market cap.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 8, 2016 7:18 AM Flag

    I just had a GREAT idea. Maybe we could put the sugar pill IN the cup of coffee and get a greater effect !!! Right.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 8, 2016 7:11 AM Flag

    Yep, and now the FDA, after reviewing our data, granted orphan status for our sugar pill and cup of coffee.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 7, 2016 6:02 AM Flag

    You think you are angry now, just wait until a couple of years from now when you say "I once owned AVXL and sold it."

    Sentiment: Strong Buy

  • Reply to

    Expectations

    by mr32slim Mar 24, 2016 1:28 PM
    me2yousee me2yousee Mar 24, 2016 2:09 PM Flag

    I applaud your rationality. At least you are consistent. And at the same time, I ask you who you think your helping?

    Our market cap is 1 /5th of AXON that FAILED. Imagine that and read that again. Same product area and 1/5th the value. If you look at the chart you can see we dropped into a negative MACD (distribution) cycle. Hard to find ANY positive expectations at this point at all. Absolute ZERO on the hype scale. Virtually the cheapest biotech on any exchange you can find. Try and find one that is cheaper. We are below even the failures.

    Nope, I want people thinking positive and ahead because the statistics are that you lose better than 50% of current shareholders at a double. The reason that figure is so high is BECUASE people WEREN'T prepared for what if. I WANT to have people around two years from now.

    Sentiment: Strong Buy

  • me2yousee by me2yousee Mar 24, 2016 12:12 PM Flag

    CPXX had a leak for their information and the stock traded like 10 mil shares and was up $.40 before the information was released. Then it gapped over 300%. Since our information is in the hands of contract vendors, I figure that a lot of phone calls are going to be made and trades executed before the actual release happens. We have almost the exact same amount of shares outstanding as CPXX.

    It might pay for folks here to look at a chart of CPXX and see how the stock has been trading since CPXX breaks the recent bio news pattern of blast then fall back. Notice the big names that have been getting into the stock at the inflated prices.

    I kind of expect that here after our reputation has been trashed by the ambulance chasers day in and day out for almost two months. My conclusion was not to be in a hurry to sell. Plan ahead.

    Sentiment: Strong Buy

  • Shorts are absolutely upset that they are missing a down cycle. But consider that once the news is released, the stock is going to jump however far and present a world class chance to short at even higher levels than it sells for today.

    If I was a short, I would be praying for great news. The guys that appear to be short here are just mouth pieces that work for some organization with some agenda. Like the motor / horsepower boys for instance. Both pick car stuff names because they have adjoining cubicles and think nobody will notice. :)

    Sentiment: Strong Buy

  • Reply to

    Don't you wonder what they do all day?

    by whatsallthehubub Mar 23, 2016 9:32 PM
    me2yousee me2yousee Mar 24, 2016 6:33 AM Flag

    It's called overhead. Now you know why AVXL contracts everything out and HAS no employees. Or has no lab equipment to go obsolete. Or buildings and grounds that have to be maintained. Why their burn rate is so low.

    Sentiment: Strong Buy

  • Reply to

    The reason they haven't posted PhaseII data is

    by stephata75 Mar 21, 2016 2:17 PM
    me2yousee me2yousee Mar 24, 2016 6:28 AM Flag

    If AVXL does have a partner, and depending on who that partner is, that partner may not want the specifics released to prevent follow on competition. BP doesn't want the competition fishing in their pond until they have caught most of the fish.

    Sentiment: Strong Buy